Lv34
290 积分 2022-01-11 加入
Drug Discovery Stories
2天前
已完结
Beyond First-Generation KRAS Inhibitors: BBO-8520 Tests the Dual Mechanism Hypothesis
2天前
求助中
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
27天前
已完结
A New Wave of PI3Kα Inhibitors
1个月前
已完结
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
1个月前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
1个月前
已完结
Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
1个月前
已完结
Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
1个月前
已完结
Discovery and development of the anticancer agent gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase
1个月前
已完结
The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase
1个月前
已完结
皖公网安备34019202002308
